Clinical Trial Search

Primary: Successful Recruitment and Randomization of 40 Postpartum Women Into the PROMPT Study — 16; 14; 2; 2 Participants

Primary: FeNO — 14.3; 34.3; 36.0; 49 parts per billion — p=<0.1

Primary: Change in Serum Phosphate in Adults and Children With XLH Between Baseline and 12 Months — 2.6; 2.1 mg/dl — p=0.318

Primary: C-PEPTIDE Suppression During Hyperinsulinemia Euglycemia. — 0.51; 0.56; 0.59 ng/mL

Primary: Pain as Measured by the FLACC Pain Scale — 0; 0; 0; 0 score on a scale — p=0.3046

Primary: FEV1 Percent Change Post-ipratropium — 10.8 percent change — p=0.032

Primary: Changes in Cytokines — 0.2473; -0.04988; -0.1137; -0.05875 pg/ml

Primary: The Hospital Anxiety and Depression Scale (HADS) - Anxiety Subscale — 10.32; 8.26; 8.96 units on scale

Primary: Cravings — 11.90; 8.94; 11.10; 8.21 score on a scale (total score, 0 to 30) — p=0.12

Primary: Correlation Between Subharmonic Aided Pressure Estimation (SHAPE) Results and Direct Measurements of Interstitial Fluid Pressure (IFP) — 0.2 Correlation coefficient…

Primary: Percent of Ki-67 Positive Cells — .4023; .5872; .3732; .5035 percentage of stained tumor cell nuclei

Primary: Pre-treatment OSCC Morphology and PDPN Expression — 2.8; 3.4; 2.5 score on a scale from 1 to 5 — p=<0.05

Primary: Duration of Response — 8.1 months

Primary: B-cell Density Stained Area — 0.027 mm^2/mm^2

Primary: Change in Carotid Artery Compliance in mm/mmHg x 10-1 — 0.88; 0.87; 0.90; 0.79 mm/mmHg x 10-1